Skip to content

Industries · Life Sciences

Planisware expertise for life sciences portfolios.

Delivery experience in enterprise biopharmaceutical environments — where R&D portfolios are complex, governance is rigorous and planning data drives major investment decisions.

  • Pharmaceutical
  • Biotechnology
  • Medical Device

Delivery experience within top global biopharmaceutical organizations.

The context

Why life sciences portfolios are different.

The platform is the same. The planning problem is not — and configuration has to reflect it.

  1. 01

    Long-horizon R&D pipelines

    Programs span years and development phases, and plans must adapt as assets progress, pause or stop.

  2. 02

    Governance-heavy decisions

    Portfolio reviews and stage-gate decisions depend on consistent, well-defined and auditable data.

  3. 03

    Shared, constrained resources

    Specialist functions support many programs at once, making capacity and demand planning central to delivery.

  4. 04

    Complex financial planning

    Budgets, forecasts and actuals need to reconcile across programs, functions and finance systems.

  5. 05

    Controlled change

    Platform changes typically move through formal change control, documented testing and release governance.

Segments

Across life sciences.

Pharmaceutical

Large, multi-phase R&D portfolios with enterprise governance and globally shared functions.

Biotechnology

Growing pipelines where planning maturity has to scale quickly with the organization.

Medical Device

Product development portfolios balancing engineering, regulatory and commercial milestones.

Beyond life sciences

The same platform depth applies to other complex enterprise environments, with delivery experience in large retail, aerospace & defense, and oil & gas organizations.

Discuss Your Environment

Planning a life sciences Planisware initiative?

Whether it's an implementation, a reporting overhaul, an upgrade or additional delivery capacity, we'd welcome the conversation.